Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

KOS

Kosmos Energy Ltd

Apr 25 • 04:00PM ET

5.83

Dollar change -0.12
Percentage change -2.02	%

Energy • Oil & Gas E&P • USA • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: IWM AVUV VXF IWO VDE SCHA VTWO FNDA DFAS FCG

Index	RUT	P/E	13.12	EPS (ttm)	0.44	Insider Own	2.26%	Shs Outstand	471.50M	Perf Week	-3.80%
Market Cap	2.75B	Forward P/E	6.53	EPS next Y	0.89	Insider Trans	-15.06%	Shs Float	460.82M	Perf Month	3.00%
Income	213.52M	PEG	0.55	EPS next Q	0.17	Inst Own	96.06%	Short Float	8.56%	Perf Quarter	-7.17%
Sales	1.72B	P/S	1.60	EPS this Y	-2.28%	Inst Trans	0.35%	Short Ratio	4.85	Perf Half Y	-18.80%
Book/sh	2.24	P/B	2.60	EPS next Y	15.70%	ROA	4.49%	Short Interest	39.43M	Perf Year	-7.90%
Cash/sh	0.20	P/C	28.83	EPS next 5Y	23.80%	ROE	23.46%	52W Range	5.23 - 8.28	Perf YTD	-13.11%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	6.21%	52W High	-29.59%	Beta	2.37
Dividend TTM	-	Quick Ratio	0.49	Sales past 5Y	26.57%	Gross Margin	48.96%	52W Low	11.47%	ATR (14)	0.23
Dividend Ex-Date	Mar 04, 2020	Current Ratio	0.76	EPS Y/Y TTM	-6.52%	Oper. Margin	42.74%	RSI (14)	45.31	Volatility	2.92% 4.12%
Employees	243	Debt/Eq	2.33	Sales Y/Y TTM	-23.90%	Profit Margin	12.42%	Recom	1.36	Target Price	8.40
Option/Short	Yes / Yes	LT Debt/Eq	2.33	EPS Q/Q	117.91%	Payout	0.00%	Rel Volume	0.46	Prev Close	5.95
Sales Surprise	7.51%	EPS Surprise	29.17%	Sales Q/Q	0.74%	Earnings	May 07 BMO	Avg Volume	8.13M	Price	5.83
SMA20	-2.93%	SMA50	-0.89%	SMA200	-12.44%	Trades		Volume	3,725,326	Change	-2.02%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-20-23	Initiated	Stifel	Buy	$10
Oct-17-23	Downgrade	Bernstein	Outperform → Mkt Perform	$12 → $9
Sep-27-23	Upgrade	BofA Securities	Neutral → Buy	$8.70 → $10
Jul-20-23	Initiated	Redburn	Buy	$9
Mar-10-23	Initiated	Peel Hunt	Add	$8.94
Feb-28-23	Downgrade	BofA Securities	Buy → Neutral	$10 → $9.60
Feb-09-23	Initiated	The Benchmark Company	Buy	$10
Aug-25-22	Upgrade	Berenberg	Hold → Buy	$8.30 → $8.50
Jun-13-22	Downgrade	Berenberg	Buy → Hold
Nov-11-21	Upgrade	Barclays	Equal Weight → Overweight	$3.95
Oct-15-21	Upgrade	Berenberg	Hold → Buy
Jun-21-21	Upgrade	Bernstein	Mkt Perform → Outperform
Jun-08-21	Upgrade	Johnson Rice	Accumulate → Buy	$4.50 → $6.25
May-17-21	Upgrade	BofA Securities	Neutral → Buy	$3.50 → $3.70
Mar-09-21	Upgrade	Johnson Rice	Hold → Accumulate
Feb-24-21	Downgrade	Berenberg	Buy → Hold
Feb-23-21	Upgrade	Goldman	Neutral → Buy	$2.40 → $4.50
May-14-20	Downgrade	Goldman	Buy → Neutral
May-13-20	Upgrade	RBC Capital Mkts	Underperform → Sector Perform
Apr-21-20	Downgrade	Investec	Buy → Hold

Show Previous Ratings

Apr-11-24 02:00AM	Kosmos Energy to Host First Quarter 2024 Results and Webcast on May 07, 2024 (Business Wire)
Mar-28-24 01:59PM	10 Best Affordable Stocks Under $10 (Insider Monkey)
09:31AM	Senegals New Leader Plans to Revisit Oil Deals with BP, Kosmos (Bloomberg)
Mar-26-24 04:14PM	3 Stocks Set to Outperform in the Next Bull Market (InvestorPlace)
Mar-08-24 09:43AM	13 Oil Stocks with Biggest Upside (Insider Monkey)
02:00AM	Loading…
Mar-06-24 02:00AM	Kosmos Energy Ltd. Prices Upsized Offering of $350 Million 3.125% Convertible Senior Notes Due 2030 (Business Wire)
Mar-04-24 04:08PM	Kosmos Energy Ltd. Announces Offering Of $300 Million Of Convertible Senior Notes Due 2030 (Business Wire)
Feb-28-24 10:53AM	Kosmos Energy Ltd. (NYSE:KOS) Q4 2023 Earnings Call Transcript (Insider Monkey)
08:38AM	In Shooting for the Stars, Kosmos Production Soars (Hart Energy)
Feb-27-24 01:29AM	Q4 2023 Kosmos Energy Ltd Earnings Call (Thomson Reuters StreetEvents)
Feb-26-24 06:52AM	Kosmos Energy Ltd (KOS) Reports Solid Q4 and Full Year 2023 Financial Results (GuruFocus.com)
05:07AM	Kosmos Energy: Q4 Earnings Snapshot (Associated Press Finance)
02:00AM	Kosmos Energy Announces Fourth Quarter and Full Year 2023 Results (Business Wire)
Feb-08-24 02:23AM	Insider Sell: SVP, Chief Commercial Officer Christopher Ball Sells 247,622 Shares of Kosmos ... (GuruFocus.com)
Feb-06-24 06:50AM	Senegal Delays Election, Sparking Unrest and Fears Over Economy (Bloomberg)
07:55AM	Loading…
Feb-05-24 07:55AM	Senegal Bonds Sink After Presidential Election Is Postponed (Bloomberg) -6.22%
Feb-01-24 07:50PM	7 Energy Stocks to Double Your Money by 2025 (InvestorPlace)
Jan-31-24 05:11AM	Kosmos Energy (KOS) Dropped Due to Lower Energy Prices (Insider Monkey)
Jan-18-24 02:00AM	Kosmos Energy to Host Fourth Quarter 2023 Results and Webcast on February 26, 2024 (Business Wire)
Jan-15-24 01:00PM	Kosmos Energy Stock (NYSE:KOS): Bearish Options Traders are Barking Up the Wrong Tree (TipRanks)
Nov-13-23 07:15PM	13 Cheap Energy Stocks To Buy (Insider Monkey)
Nov-09-23 10:00AM	Plethora of Projects to Boost Kosmos Energys Future (Hart Energy) +5.78%
Nov-07-23 11:11AM	Kosmos Energy Ltd. (NYSE:KOS) Q3 2023 Earnings Call Transcript (Insider Monkey) -5.10%
01:12AM	Q3 2023 Kosmos Energy Ltd Earnings Call (Thomson Reuters StreetEvents)
Nov-06-23 10:06AM	REFILE-Kosmos says Tortue LNG project start-up could slip into Q2 24 (Reuters) -6.61%
08:17AM	Kosmos Energy Ltd (KOS) Reports Q3 2023 Earnings: Net Income of $85 Million, Revenue of $526 Million (GuruFocus.com)
05:03AM	Kosmos Energy: Q3 Earnings Snapshot (Associated Press Finance)
02:00AM	Kosmos Energy Increases Working Interest and Assumes Operatorship of Yakaar-Teranga (Business Wire)
02:00AM	Kosmos Energy Announces Third Quarter 2023 Results (Business Wire)
Nov-02-23 05:46AM	What Makes Kosmos Energy (KOS) an Acquisition Target? (Insider Monkey)
02:39AM	Loading…
Oct-17-23 02:39AM	A one-two punch for SunPower ahead of slashed solar incentives: 5 big analyst cuts (Investing.com)
Oct-12-23 08:24AM	Kosmos (KOS) Finds Success in GoM With Tiberius Oil Find (Zacks)
Oct-11-23 02:00AM	Kosmos Energy Announces Oil Discovery in the U.S. Gulf of Mexico (Business Wire)
Oct-06-23 02:00AM	Kosmos Energy to Host Third Quarter 2023 Results and Webcast on November 6, 2023 (Business Wire)
Oct-04-23 12:36PM	Unveiling Kosmos Energy (KOS)'s Value: Is It Really Priced Right? A Comprehensive Guide (GuruFocus.com) -8.57%
Sep-28-23 03:10AM	General Dynamics rated Buy at Deutsche, XPO gains on upgrade: 4 big analyst picks (Investing.com)
Sep-26-23 07:34PM	Unveiling Kosmos Energy (KOS)'s Value: Is It Really Priced Right? A Comprehensive Guide (GuruFocus.com)
Sep-16-23 08:34AM	10 Best African Stocks To Invest In (Insider Monkey)
Sep-13-23 10:53AM	We Stay Selective: Blackrock Snaps Up These 2 Buy-Rated Stocks Heres Why You Should Pay Attention (TipRanks)
Aug-09-23 09:51AM	Kosmos Energy Ltd. (NYSE:KOS) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-08-23 03:26AM	Q2 2023 Kosmos Energy Ltd Earnings Call (Thomson Reuters StreetEvents)
Aug-07-23 05:02AM	Kosmos Energy: Q2 Earnings Snapshot (AP Finance)
02:00AM	Kosmos Energy Announces Second Quarter 2023 Results (Business Wire)
Jul-22-23 08:24AM	Is Kosmos Energy Ltd. (NYSE:KOS) Trading At A 42% Discount? (Simply Wall St.)
Jul-14-23 02:00AM	Start Up of the Jubilee South East Project (Business Wire) -5.43%
Jul-06-23 02:00AM	Kosmos Energy to Host Second Quarter 2023 Results and Webcast on August 7, 2023 (Business Wire)
Jun-28-23 02:06PM	Even though Kosmos Energy (NYSE:KOS) has lost US$290m market cap in last 7 days, shareholders are still up 227% over 3 years (Simply Wall St.)
Jun-12-23 08:53AM	Zacks Industry Outlook Highlights Kosmos Energy, Tullow Oil and Capricorn Energy (Zacks)
Jun-08-23 07:53AM	Fewer Investors Than Expected Jumping On Kosmos Energy Ltd. (NYSE:KOS) (Simply Wall St.)
May-09-23 05:03AM	Kosmos Energy: Q1 Earnings Snapshot (AP Finance)
02:00AM	Kosmos Energy Announces First Quarter 2023 Results (Business Wire)
Apr-26-23 02:00AM	Kosmos Energy Announces New Appointments to Board of Directors (Business Wire)
Apr-19-23 02:00AM	Kosmos Energy to Host First Quarter 2023 Results and Webcast on May 9, 2023 (Business Wire)
Apr-11-23 01:30PM	Is Kosmos Energy Ltd.'s (NYSE:KOS) ROE Of 29% Impressive? (Simply Wall St.)
Mar-17-23 05:54PM	15 Best Stocks Under $10 To Buy Now (Insider Monkey)
Mar-12-23 11:55PM	Kosmos Energy Ltd. (NYSE:KOS) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-04-23 09:08AM	17 High Growth Low PE Stocks (Insider Monkey)
Mar-01-23 10:10AM	What's the Breakout Point on Under-the Radar Kosmos Energy? (TheStreet.com)
Feb-28-23 03:52AM	Q4 2022 Kosmos Energy Ltd Earnings Call (Thomson Reuters StreetEvents) -7.95%
Feb-27-23 02:02AM	Kosmos Energy Announces Fourth Quarter and Full Year 2022 Results (Business Wire) +13.10%
Feb-02-23 06:29AM	Is There An Opportunity With Kosmos Energy Ltd.'s (NYSE:KOS) 20% Undervaluation? (Simply Wall St.) -5.66%
Jan-27-23 02:00AM	Kosmos Energy to Host Fourth Quarter 2022 Results and Webcast on February 27, 2023 (Business Wire)
Jan-23-23 06:55AM	Kosmos Energy Announces Greater Tortue Ahmeyim FPSO Sailaway (Business Wire)
Jan-04-23 06:00PM	Kosmos Energy (KOS) Outpaces Stock Market Gains: What You Should Know (Zacks)
Dec-31-22 09:43AM	Investing in Kosmos Energy (NYSE:KOS) a year ago would have delivered you a 84% gain (Simply Wall St.)
Dec-27-22 11:39AM	Our Top 7 Oil Stock Predictions for 2023 (InvestorPlace)
Dec-20-22 09:24AM	12 Oil Stocks With Biggest Upside (Insider Monkey)
Dec-05-22 09:40AM	Are Oils-Energy Stocks Lagging Kosmos Energy (KOS) This Year? (Zacks) -6.23%
Nov-17-22 09:40AM	Is Kosmos Energy (KOS) Stock Outpacing Its Oils-Energy Peers This Year? (Zacks)
Nov-10-22 07:26AM	Kosmos Energy Third Quarter 2022 Earnings: EPS: US$0.49 (vs US$0.07 loss in 3Q 2021) (Simply Wall St.)
Nov-07-22 09:55AM	Can Kosmos Energy (KOS) Climb 38% to Reach the Level Wall Street Analysts Expect? (Zacks) +7.33%
02:00AM	Kosmos Energy Announces Third Quarter 2022 Results (Business Wire)
Nov-02-22 12:20PM	How Did Kosmos Energy Ltd.'s (NYSE:KOS) 28% ROE Fare Against The Industry? (Simply Wall St.)
Oct-25-22 01:57PM	Find Cheap Stocks Under $10 to Buy During the Recent Market Rebound (Zacks)
08:32AM	10 Energy Stocks To Buy On the OPEC Production Cuts (Insider Monkey)
06:12AM	10 Cheap Oil Stocks Under $10 (Insider Monkey)
Oct-20-22 01:23PM	7 Oil Stock Predictions for 2023 (InvestorPlace)
09:55AM	Wall Street Analysts Believe Kosmos Energy (KOS) Could Rally 52%: Here's is How to Trade (Zacks)
09:30AM	Kosmos Energy (KOS) Just Overtook the 200-Day Moving Average (Zacks)
Oct-18-22 01:08PM	10 Oil Stocks To Buy That Are Too Cheap To Ignore (Insider Monkey)
02:00AM	Kosmos Energy to Host Third Quarter 2022 Results and Webcast on November 7, 2022 (Business Wire)
Sep-27-22 02:00AM	Kosmos Energy Provides Further Update on Greater Tortue Ahmeyim FPSO (Business Wire)
Sep-24-22 05:30AM	2 Top Energy Stocks to Buy Right Now (Motley Fool)
Sep-23-22 02:25PM	7 A-Rated Stocks to Buy for Less Than $10 (InvestorPlace) -13.38%
Sep-16-22 05:00PM	Kosmos Energy Provides Update on Greater Tortue Ahmeyim FPSO (Business Wire)
Sep-05-22 09:35AM	Kosmos Energy (KOS) Crossed Above the 20-Day Moving Average: What That Means for Investors (Zacks)
Aug-30-22 11:15AM	5 Best-Performing Stocks of the Top ETF of August (Zacks) -6.72%
Aug-26-22 07:09AM	Kosmos Energy Ltd.'s (NYSE:KOS) Intrinsic Value Is Potentially 99% Above Its Share Price (Simply Wall St.)
Aug-19-22 03:35PM	Energy stocks: Is there room for more upside? Experts weigh in (Yahoo Finance)
09:30AM	Kosmos Energy (KOS) Just Reclaimed the 50-Day Moving Average (Zacks)
Aug-08-22 05:00PM	Kosmos Energy (KOS) Q2 2022 Earnings Call Transcript (Motley Fool)
09:35AM	Kosmos Energy (KOS) Just Overtook the 20-Day Moving Average (Zacks)
02:00AM	Kosmos Energy Announces Second Quarter 2022 Results (Business Wire)
Aug-01-22 09:55AM	How Much Upside is Left in Kosmos Energy (KOS)? Wall Street Analysts Think 50% (Zacks)
Jul-26-22 06:00PM	Kosmos Energy (KOS) Stock Moves -0.17%: What You Should Know (Zacks)
Jul-24-22 09:24AM	Investing in Kosmos Energy (NYSE:KOS) a year ago would have delivered you a 138% gain (Simply Wall St.)
Jul-21-22 02:00AM	Kosmos Energy to Host Second Quarter 2022 Results and Webcast on August 8, 2022 (Business Wire)
Jul-20-22 06:15PM	Kosmos Energy (KOS) Gains But Lags Market: What You Should Know (Zacks)
Jul-14-22 06:17PM	Kosmos Energy (KOS) Dips More Than Broader Markets: What You Should Know (Zacks)
Jul-08-22 06:15PM	Kosmos Energy (KOS) Flat As Market Sinks: What You Should Know (Zacks)

Kosmos Energy Ltd. engages in the exploration, development, and production of oil and gas. The firm's assets include production offshore Ghana, Equatorial Guinea and the U.S. Gulf of Mexico, as well as a gas development offshore Mauritania and Senegal. It also maintains a sustainable exploration program balanced between proven basin infrastructure-led exploration, emerging basins, and frontier basins. The company was founded by Brian F. Maxted on April 23, 2003 and is headquartered in Dallas, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
INGLIS ANDREW G	Chairman and CEO	Feb 06 '24	Sale	5.66	177,430	1,003,917	3,376,816	Feb 07 04:19 PM
Ball Christopher James	SVP, Chief Commercial Officer	Feb 06 '24	Sale	5.66	121,915	689,807	1,409,244	Feb 07 04:16 PM
Shah Nealesh D.	SVP and CFO	Feb 06 '24	Sale	5.66	90,454	511,798	1,230,830	Feb 07 04:20 PM
Doughty Jason	SVP and General Counsel	Feb 06 '24	Sale	5.66	71,227	403,009	1,244,324	Feb 07 04:17 PM
Glass Ronald W.	VP & Chief Accounting Officer	Feb 06 '24	Sale	5.66	18,693	105,767	234,773	Feb 07 04:18 PM
INGLIS ANDREW G	Chairman and CEO	Feb 05 '24	Sale	5.49	182,948	1,003,927	3,554,246	Feb 07 04:19 PM
Ball Christopher James	SVP, Chief Commercial Officer	Feb 05 '24	Sale	5.49	125,707	689,817	1,531,159	Feb 07 04:16 PM
Shah Nealesh D.	SVP and CFO	Feb 05 '24	Sale	5.49	93,267	511,803	1,321,284	Feb 07 04:20 PM
Doughty Jason	SVP and General Counsel	Feb 05 '24	Sale	5.49	73,442	403,013	1,315,551	Feb 07 04:17 PM
Glass Ronald W.	VP & Chief Accounting Officer	Feb 05 '24	Sale	5.49	19,274	105,766	253,466	Feb 07 04:18 PM
INGLIS ANDREW G	Chairman and CEO	Feb 02 '24	Sale	5.84	171,941	1,003,929	3,737,194	Feb 02 05:53 PM
Ball Christopher James	SVP, Chief Commercial Officer	Feb 02 '24	Sale	5.84	118,144	689,819	1,656,866	Feb 02 05:46 PM
Shah Nealesh D.	SVP and CFO	Feb 02 '24	Sale	5.84	87,655	511,800	1,414,551	Feb 02 05:55 PM
Doughty Jason	SVP and General Counsel	Feb 02 '24	Sale	5.84	69,025	403,023	1,388,993	Feb 02 05:49 PM
Glass Ronald W.	VP & Chief Accounting Officer	Feb 02 '24	Sale	5.84	18,115	105,770	272,740	Feb 02 05:51 PM
INGLIS ANDREW G	Chairman and CEO	Feb 01 '24	Sale	6.03	166,524	1,003,923	3,909,135	Feb 02 05:53 PM
Ball Christopher James	SVP, Chief Commercial Officer	Feb 01 '24	Sale	6.03	114,423	689,822	1,775,010	Feb 02 05:46 PM
Shah Nealesh D.	SVP and CFO	Feb 01 '24	Sale	6.03	84,672	510,462	1,502,206	Feb 02 05:55 PM
Doughty Jason	SVP and General Counsel	Feb 01 '24	Sale	6.03	66,616	401,608	1,458,018	Feb 02 05:49 PM
Glass Ronald W.	VP & Chief Accounting Officer	Feb 01 '24	Sale	6.03	17,525	105,653	290,855	Feb 02 05:51 PM
GOODWIN DEANNA L	Director	Jun 09 '23	Sale	6.69	112,000	749,280	99,532	Jun 12 04:08 PM
Franklin Roy A.	Director	Jun 09 '23	Sale	6.80	8,000	54,400	68,870	Jun 12 04:06 PM

Open in Screener

NBIX

Neurocrine Biosciences, Inc.

Apr 25 • 04:00PM ET

137.76

Dollar change -1.21
Percentage change -0.87	%

Healthcare • Drug Manufacturers - Specialty & Generic • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

NBIX Neurocrine Biosciences, Inc. daily Stock Chart

Held by: VTI IJH VB VXF VBK USMV IBB IJK IWP VHT

Index	-	P/E	56.69	EPS (ttm)	2.43	Insider Own	2.60%	Shs Outstand	98.70M	Perf Week	3.94%
Market Cap	13.71B	Forward P/E	19.70	EPS next Y	6.99	Insider Trans	-22.95%	Shs Float	96.92M	Perf Month	-2.41%
Income	249.70M	PEG	3.15	EPS next Q	1.10	Inst Own	92.83%	Short Float	2.09%	Perf Quarter	-2.30%
Sales	1.89B	P/S	7.26	EPS this Y	105.20%	Inst Trans	-1.46%	Short Ratio	2.29	Perf Half Y	26.10%
Book/sh	22.61	P/B	6.09	EPS next Y	37.98%	ROA	8.71%	Short Interest	2.02M	Perf Year	34.57%
Cash/sh	10.37	P/C	13.29	EPS next 5Y	18.00%	ROE	12.68%	52W Range	89.04 - 148.37	Perf YTD	4.55%
Dividend Est.	-	P/FCF	37.91	EPS past 5Y	62.04%	ROI	10.03%	52W High	-7.15%	Beta	0.28
Dividend TTM	-	Quick Ratio	2.40	Sales past 5Y	34.77%	Gross Margin	96.95%	52W Low	54.72%	ATR (14)	4.34
Dividend Ex-Date	Dec 29, 1995	Current Ratio	2.45	EPS Y/Y TTM	57.90%	Oper. Margin	20.92%	RSI (14)	52.71	Volatility	3.19% 2.93%
Employees	1400	Debt/Eq	0.21	Sales Y/Y TTM	26.76%	Profit Margin	13.23%	Recom	1.68	Target Price	154.10
Option/Short	Yes / Yes	LT Debt/Eq	0.12	EPS Q/Q	63.53%	Payout	0.00%	Rel Volume	0.84	Prev Close	138.97
Sales Surprise	-0.64%	EPS Surprise	18.81%	Sales Q/Q	25.05%	Earnings	May 01 BMO	Avg Volume	880.83K	Price	137.76
SMA20	0.88%	SMA50	1.00%	SMA200	13.86%	Trades		Volume	735,676	Change	-0.87%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-24-24	Upgrade	Wells Fargo	Equal Weight → Overweight	$140 → $170
Dec-13-23	Resumed	Citigroup	Neutral	$127
Dec-12-23	Initiated	Deutsche Bank	Buy	$136
Oct-24-23	Resumed	Cantor Fitzgerald	Overweight	$135 → $140
Aug-21-23	Reiterated	Mizuho	Neutral	$112 → $113
Jul-24-23	Upgrade	SVB Securities	Market Perform → Outperform	$115 → $125
Jul-06-23	Upgrade	BMO Capital Markets	Underperform → Market Perform	$91 → $96
May-04-23	Upgrade	Guggenheim	Neutral → Buy	$145
Mar-30-23	Upgrade	Canaccord Genuity	Hold → Buy	$124 → $132
Mar-03-23	Upgrade	Evercore ISI	In-line → Outperform	$130
Feb-03-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$120 → $130
Nov-14-22	Downgrade	Evercore ISI	Outperform → In-line	$140 → $130
Oct-11-22	Initiated	UBS	Buy	$136
Sep-26-22	Initiated	Wells Fargo	Equal Weight	$110
Jun-06-22	Resumed	Jefferies	Buy	$126 → $112
Mar-03-22	Downgrade	Piper Sandler	Overweight → Neutral	$114 → $94
Feb-25-22	Upgrade	Goldman	Neutral → Buy	$115
Jan-18-22	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$122 → $90
Nov-19-21	Initiated	BMO Capital Markets	Underperform	$76
Nov-17-21	Upgrade	JP Morgan	Neutral → Overweight	$124

Show Previous Ratings

Apr-24-24 10:15AM	Does Neurocrine, The No. 1 Biotech Stock, Have The Next Ketamine On Its Hands? (Investor's Business Daily)
10:01AM	Neurocrine Biosciences (NBIX) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
08:30AM	Neurocrine Biosciences Launches WHAT THE C@H?! Educational Initiative to Support Congenital Adrenal Hyperplasia Community (PR Newswire)
Apr-23-24 11:50AM	No. 1 Biotech Stock Neurocrine Launches Higher On Depression Treatment Win (Investor's Business Daily)
07:22AM	Neurocrine scores surprise win with depression drug (BioPharma Dive)
07:00AM	Loading…
07:00AM	Neurocrine Biosciences Reports Positive Phase 2 Data for NBI-1065845 in Adults with Major Depressive Disorder (PR Newswire)
Apr-22-24 11:10AM	10 Best Performing Biotech ETFs in 2024 (Insider Monkey)
Apr-16-24 04:01PM	Sentia Medical Sciences and Neurocrine Biosciences Extend Research Collaboration to Discover Novel CRF Peptides (GlobeNewswire)
02:30AM	Nxera Pharma Notes Successful Development Progress of Partnered Schizophrenia Candidate NBI-1117568 (GlobeNewswire)
Apr-10-24 04:01PM	Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2024 Financial Results (PR Newswire)
Apr-09-24 07:37AM	11 Best Biotech ETFs To Buy (Insider Monkey)
Apr-03-24 08:30AM	Neurocrine Biosciences Announces First-Patient Dosed in Phase 2 Clinical Study Evaluating NBI-1070770 in Adults with Major Depressive Disorder (PR Newswire)
Mar-28-24 08:30AM	Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1065890, a Second-Generation VMAT2 Inhibitor, in Healthy Adults (PR Newswire)
Mar-24-24 09:19AM	Top 12 Stocks in George Soros' Stock Portfolio (Insider Monkey)
Mar-23-24 08:00AM	S&P 500 Giants Lead Five Stocks Near Buy Points With Fed's Powell A Tailwind (Investor's Business Daily)
08:00AM	Loading…
Mar-16-24 08:00AM	AI Plays HubSpot, Arista Networks Lead Five Stocks Near Buy Points In Classic Base (Investor's Business Daily)
01:23AM	Neurocrine Biosciences Inc's Chief Regulatory Officer Ingrid Delaet Sells 3,000 Shares (GuruFocus.com)
01:23AM	Director Richard Pops Sells 23,200 Shares of Neurocrine Biosciences Inc (NBIX) (GuruFocus.com)
Mar-15-24 10:00AM	Neurocrine Biosciences Is Pioneering Therapies for Neurological Disorders (GuruFocus.com)
Mar-13-24 01:26AM	Director Richard Pops Sells Shares of Neurocrine Biosciences Inc (NBIX) (GuruFocus.com)
Mar-11-24 04:01PM	Neurocrine Biosciences to Participate at Virtual Investor Conferences in March (PR Newswire)
01:12PM	The $1 Billion Opportunity Driving IBD Stock Of The Day Neurocrine Higher (Investor's Business Daily)
Mar-06-24 04:45PM	3 Cutting-Edge Biotech Stocks Sitting on the Brink of Success (InvestorPlace)
Mar-01-24 12:40AM	Neurocrine Biosciences Inc's Chief Regulatory Officer Ingrid Delaet Sells Company Shares (GuruFocus.com)
Feb-27-24 04:01PM	Neurocrine Biosciences to Participate at Investor Conferences in March (PR Newswire)
Feb-22-24 11:28PM	Director Richard Pops Sells 15,000 Shares of Neurocrine Biosciences Inc (GuruFocus.com)
03:55AM	11 Best Small-Cap Growth Stocks to Invest In (Insider Monkey)
Feb-15-24 11:36PM	Neurocrine Biosciences Inc's Chief Commercial Officer Eric Benevich Sells Company Shares (GuruFocus.com)
Feb-10-24 10:18AM	Wall Street Analysts Just Trimmed Price Targets for These 10 Stocks (Insider Monkey)
12:14AM	Decoding Neurocrine Biosciences Inc (NBIX): A Strategic SWOT Insight (GuruFocus.com)
02:23AM	Loading…
Feb-09-24 02:23AM	Neurocrine Biosciences Inc's Chief Commercial Officer Eric Benevich Sells Company Shares (GuruFocus.com)
Feb-08-24 09:13AM	Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Q4 2023 Earnings Call Transcript (Insider Monkey)
12:20AM	Q4 2023 Neurocrine Biosciences Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-07-24 09:30AM	Neurocrine (NBIX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
07:33AM	Neurocrine Biosciences Inc (NBIX) Reports Strong Growth in INGREZZA Sales for Q4 and Full Year 2023 (GuruFocus.com)
07:18AM	Neurocrine: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Neurocrine Biosciences Reports Fourth Quarter and Fiscal 2023 Financial Results and Provides Financial Expectations for 2024 (PR Newswire)
Feb-05-24 09:16AM	Ahead of Neurocrine (NBIX) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics (Zacks)
Feb-02-24 11:02PM	Neurocrine Biosciences Inc CFO Matt Abernethy Sells Company Shares (GuruFocus.com)
Jan-31-24 10:00AM	Neurocrine Biosciences (NBIX) Earnings Expected to Grow: Should You Buy? (Zacks)
Jan-24-24 11:02PM	Neurocrine Biosciences Inc's Chief Legal Officer Sells Shares (GuruFocus.com)
06:54AM	Neurocrine Biosciences is Under Heavy Accumulation, The One Chart that Matters (FX Empire)
Jan-22-24 09:38AM	Growth Stock Portfolio: 15 Companies with At Least 30% Annual Growth Rates (Insider Monkey)
Jan-17-24 04:16PM	Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2023 Financial Results (PR Newswire)
Jan-12-24 09:35AM	5 High Growth NASDAQ Stocks That Are Profitable (Insider Monkey)
Jan-11-24 09:02PM	Neurocrine Biosciences Inc CEO Kevin Gorman Sells 167,858 Shares (GuruFocus.com)
Jan-10-24 09:24AM	How Neurocrine (NBIX) Stock Stands Out in a Strong Industry (Zacks)
Jan-05-24 02:02AM	Director William Rastetter Sells Shares of Neurocrine Biosciences Inc (NBIX) (GuruFocus.com)
Jan-02-24 04:01PM	Neurocrine Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-26-23 06:56PM	13 High Growth Healthcare Stocks to Buy (Insider Monkey)
07:22AM	Neurocrine (NBIX) Soars 6.0%: Is Further Upside Left in the Stock? (Zacks)
Dec-25-23 08:23PM	3 Stocks at the Forefront of Medical Innovation (InvestorPlace)
Dec-20-23 04:54AM	Here's Why Neurocrine Biosciences (NBIX) Rose in Q3 (Insider Monkey)
Dec-16-23 01:01PM	Insider Sell: Chief Medical Officer Eiry Roberts Sells Shares of Neurocrine Biosciences Inc (GuruFocus.com)
Dec-15-23 02:30PM	The 3 Most Undervalued Biotech Stocks to Buy in December (InvestorPlace)
Dec-12-23 03:05PM	Insider Sell: Chief Medical Officer Eiry Roberts Sells Shares of Neurocrine Biosciences Inc (GuruFocus.com)
Dec-10-23 11:15AM	Insider Sell Alert: Chief Legal Officer Darin Lippoldt Sells Shares of Neurocrine Biosciences Inc (GuruFocus.com)
Dec-09-23 11:05AM	Insider Sell: Chief Medical Officer Eiry Roberts Sells Shares of Neurocrine Biosciences Inc (GuruFocus.com)
Dec-06-23 03:01AM	Sosei Heptares' Partner Neurocrine Biosciences Confirms its Plans to Evaluate Two New Muscarinic Agonist Candidates in Phase 1 Clinical Studies (GlobeNewswire)
Dec-05-23 04:01PM	Neurocrine Biosciences Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Crinecerfont in Congenital Adrenal Hyperplasia (PR Newswire)
Dec-02-23 05:06AM	Insider Sell Alert: Chief Scientific Officer Jude Onyia Sells Shares of Neurocrine Biosciences Inc (GuruFocus.com)
Dec-01-23 07:00AM	Neurocrine Biosciences to Host Analyst Day on December 5, 2023 (PR Newswire)
Nov-30-23 05:04AM	Neurocrine Biosciences Inc's Chief Legal Officer Darin Lippoldt Sells Shares: An Insider Analysis (GuruFocus.com)
Nov-13-23 06:07PM	12 Best Low Beta Stocks To Buy (Insider Monkey)
07:00AM	Neurocrine Biosciences Announces Settlement of INGREZZA Abbreviated New Drug Application (ANDA) Litigation (PR Newswire)
Nov-09-23 04:01PM	Neurocrine Biosciences Provides Development Pipeline Update (PR Newswire)
Nov-08-23 04:05PM	Neurocrine Biosciences Launches Interactive Digital Tool for use by Healthcare Providers to Help Expand Education on Identifying and Diagnosing Tardive Dyskinesia (PR Newswire)
04:01PM	Neurocrine Biosciences to Present at the Jefferies London Healthcare Conference (PR Newswire)
Nov-06-23 09:45AM	Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-02-23 08:30AM	Neurocrine Biosciences Presents INGREZZA (valbenazine) Capsules Interim Data Demonstrating Sustained Improvements in Chorea Associated With Huntington's Disease Through Week 50 at Huntington Study Group 2023 (PR Newswire)
Nov-01-23 06:34PM	The Neurocrine Biosciences Inc (NBIX) Company: A Short SWOT Analysis (GuruFocus.com)
Oct-31-23 09:30AM	Neurocrine (NBIX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
08:32AM	Neurocrine Biosciences Inc (NBIX) Reports 29% YoY Growth in Q3 2023 Net Product Sales (GuruFocus.com)
08:15AM	Neurocrine Biosciences (NBIX) Q3 Earnings Miss Estimates (Zacks)
07:05AM	Neurocrine: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Neurocrine Biosciences Reports Third Quarter 2023 Financial Results and Raises 2023 INGREZZA Sales Guidance (PR Newswire)
Oct-24-23 10:00AM	Neurocrine Biosciences (NBIX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-20-23 11:43AM	BEAM to Reprioritize Portfolio, Slash Jobs, Shares Tank (Zacks)
Oct-18-23 11:13AM	Lisata's (LSTA) Lead Cancer Drug Gets EC's Orphan Tag, Stock Up (Zacks)
Oct-16-23 12:53PM	Catalyst (CPRX) Seeks to Increase Maximum Daily Dose for Firdapse (Zacks)
Oct-10-23 04:01PM	Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2023 Financial Results (PR Newswire)
Oct-05-23 11:41AM	Neurocrine Biosciences (NBIX): An Undervalued Gem in the Pharmaceutical Sector? (GuruFocus.com)
07:00AM	Neurocrine Biosciences Announces Phase 3 Pediatric Study Results of Crinecerfont in Children and Adolescents for the Treatment of Congenital Adrenal Hyperplasia Met Primary and Key Secondary Endpoints (PR Newswire)
03:01AM	Insider Sell: David Boyer Sells 1,437 Shares of Neurocrine Biosciences Inc (NBIX) (GuruFocus.com)
Oct-03-23 12:45PM	Neurocrine (NBIX) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
Sep-26-23 04:32PM	The $660 Million Opportunity That's Driving IBD Stock Of The Day Neurocrine Biosciences Higher (Investor's Business Daily)
Sep-21-23 09:15AM	Neurocrine Biosciences Presents Post Hoc Data Analysis in Congenital Adrenal Hyperplasia at ESPE 2023 (PR Newswire)
Sep-14-23 07:04PM	Director Gary Lyons Sells 5,000 Shares of Neurocrine Biosciences Inc (NBIX) (GuruFocus.com)
08:30AM	Neurocrine Biosciences Announces U.S. FDA Accepts New Drug Application for INGREZZA® (valbenazine) Oral Granules Sprinkle Formulation (PR Newswire)
Sep-12-23 04:05PM	Can Neurocrine Erase Its Recent Setbacks With This Jump To An Eight-Month High? (Investor's Business Daily) +6.80%
12:18PM	Neurocrine Biosciences Inc's Meteoric Rise: Unpacking the 22% Surge in Just 3 Months (GuruFocus.com)
07:30AM	Neurocrine Biosciences Announces Positive Top-Line Data from Phase 3 Study of Crinecerfont in Adults for the Treatment of Congenital Adrenal Hyperplasia (CAH) (PR Newswire)
Sep-11-23 07:01PM	Sosei Heptares partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of NBI-1117570 in Healthy Adults (GlobeNewswire)
08:30AM	Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1117570 in Healthy Adults (PR Newswire)
Sep-06-23 08:00AM	Biden FTCs Antitrust Bark Proves Worse Than Its Bite (The Wall Street Journal)
Aug-31-23 04:01PM	Neurocrine Biosciences to Present at Upcoming Investor Conferences in September (PR Newswire)
Aug-29-23 08:30AM	Neurocrine Biosciences Presents Data at MDS International Congress of Parkinson's Disease and Movement Disorders® Demonstrating Comparable Improvement Over Time in Tardive Dyskinesia Severity and Impact Following Treatment With INGREZZA® (valbenazine) Capsules (PR Newswire)
Aug-28-23 08:30AM	Neurocrine Biosciences Presents New INGREZZA® (valbenazine) Capsules Data Demonstrating Early and Sustained Improvements in Chorea Associated With Huntington's Disease (PR Newswire)
Aug-27-23 08:53AM	14 Best Low Risk High Growth Stocks to Buy Now (Insider Monkey)
Aug-18-23 04:34PM	Neurocrine Biosciences Announces FDA Approval of INGREZZA® (valbenazine) Capsules for the Treatment of Chorea Associated With Huntington's Disease (PR Newswire)

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BENEVICH ERIC	Chief Commercial Officer	Apr 15 '24	Option Exercise	81.21	19,818	1,609,431	53,365	Apr 17 05:19 PM
BENEVICH ERIC	Chief Commercial Officer	Apr 15 '24	Sale	133.36	19,818	2,643,020	40,778	Apr 17 05:19 PM
Delaet Ingrid	Chief Regulatory Officer	Apr 01 '24	Option Exercise	79.02	272	21,493	7,779	Apr 03 04:44 PM
Delaet Ingrid	Chief Regulatory Officer	Apr 01 '24	Sale	137.30	272	37,346	7,507	Apr 03 04:44 PM
Delaet Ingrid	Chief Regulatory Officer	Mar 21 '24	Option Exercise	103.52	5,000	517,600	12,507	Mar 25 06:02 PM
Delaet Ingrid	Chief Regulatory Officer	Mar 21 '24	Sale	145.06	5,000	725,320	7,507	Mar 25 06:02 PM
BENEVICH ERIC	Chief Commercial Officer	Mar 14 '24	Option Exercise	80.90	75,000	6,067,628	110,299	Mar 15 05:33 PM
MORROW GEORGE J	Director	Mar 14 '24	Option Exercise	39.79	40,000	1,591,600	20,000	Mar 15 05:25 PM
BENEVICH ERIC	Chief Commercial Officer	Mar 14 '24	Sale	139.38	75,000	10,453,417	40,778	Mar 15 05:33 PM
MORROW GEORGE J	Director	Mar 14 '24	Sale	139.42	40,000	5,576,710	0	Mar 15 05:25 PM
POPS RICHARD F	Director	Mar 13 '24	Option Exercise	42.76	23,200	992,032	52,712	Mar 15 05:19 PM
Delaet Ingrid	Chief Regulatory Officer	Mar 13 '24	Option Exercise	106.02	3,000	318,060	10,507	Mar 15 05:15 PM
POPS RICHARD F	Director	Mar 13 '24	Sale	140.33	23,200	3,255,621	29,512	Mar 15 05:19 PM
Delaet Ingrid	Chief Regulatory Officer	Mar 13 '24	Sale	140.14	3,000	420,419	7,507	Mar 15 05:15 PM
Delaet Ingrid	Chief Regulatory Officer	Mar 11 '24	Option Exercise	106.02	200	21,204	7,707	Mar 12 06:38 PM
POPS RICHARD F	Director	Mar 11 '24	Option Exercise	42.76	100	4,276	29,612	Mar 12 06:47 PM
Delaet Ingrid	Chief Regulatory Officer	Mar 11 '24	Sale	140.00	200	28,000	7,507	Mar 12 06:38 PM
POPS RICHARD F	Director	Mar 11 '24	Sale	140.00	100	14,000	29,512	Mar 12 06:47 PM
Delaet Ingrid	Chief Regulatory Officer	Mar 08 '24	Option Exercise	106.02	1,800	190,836	9,307	Mar 12 06:38 PM
POPS RICHARD F	Director	Mar 08 '24	Option Exercise	42.76	1,700	72,692	31,212	Mar 12 06:47 PM
Delaet Ingrid	Chief Regulatory Officer	Mar 08 '24	Sale	140.03	1,800	252,053	7,507	Mar 12 06:38 PM
POPS RICHARD F	Director	Mar 08 '24	Sale	140.05	1,700	238,078	29,512	Mar 12 06:47 PM
Delaet Ingrid	Chief Regulatory Officer	Feb 29 '24	Option Exercise	79.02	273	21,572	7,780	Feb 29 07:02 PM
Delaet Ingrid	Chief Regulatory Officer	Feb 29 '24	Sale	135.51	273	36,994	7,507	Feb 29 07:02 PM
BENEVICH ERIC	Chief Commercial Officer	Feb 28 '24	Option Exercise	53.67	75,000	4,025,043	93,759	Feb 29 06:55 PM
Delaet Ingrid	Chief Regulatory Officer	Feb 28 '24	Option Exercise	79.02	6,544	517,107	10,007	Feb 29 07:02 PM
BENEVICH ERIC	Chief Commercial Officer	Feb 28 '24	Sale	134.69	75,000	10,101,608	40,616	Feb 29 06:55 PM
Delaet Ingrid	Chief Regulatory Officer	Feb 28 '24	Sale	135.34	6,544	885,638	7,507	Feb 29 07:02 PM
Norwalk Leslie V	Director	Feb 27 '24	Option Exercise	84.95	8,000	679,600	8,000	Feb 29 06:50 PM
Norwalk Leslie V	Director	Feb 27 '24	Sale	135.67	8,000	1,085,388	0	Feb 29 06:50 PM
POPS RICHARD F	Director	Feb 20 '24	Option Exercise	12.98	15,000	194,700	44,512	Feb 22 05:11 PM
POPS RICHARD F	Director	Feb 20 '24	Sale	132.47	15,000	1,987,047	29,512	Feb 22 05:11 PM
GORMAN KEVIN CHARLES	Chief Executive Officer	Feb 13 '24	Option Exercise	39.28	5,090	199,951	512,052	Feb 14 05:17 PM
GORMAN KEVIN CHARLES	Chief Executive Officer	Feb 13 '24	Sale	133.02	2,832	376,700	514,596	Feb 15 05:43 PM
Boyer David W.	Chief Corp. Affairs Officer	Feb 13 '24	Sale	133.07	1,811	240,996	4,895	Feb 15 05:33 PM
Onyia Jude	Chief Scientific Officer	Feb 13 '24	Sale	132.94	1,432	190,371	13,128	Feb 15 05:48 PM
Gano Kyle	Chief Business Development Off	Feb 13 '24	Sale	132.89	1,352	179,674	135,166	Feb 15 05:40 PM
ABERNETHY MATT	Chief Financial Officer	Feb 13 '24	Sale	132.85	1,352	179,612	31,528	Feb 15 05:27 PM
ROBERTS EIRY	Chief Medical Officer	Feb 13 '24	Sale	132.96	1,114	148,122	23,716	Feb 15 05:51 PM
BENEVICH ERIC	Chief Commercial Officer	Feb 13 '24	Sale	133.01	1,098	146,050	40,616	Feb 15 05:29 PM
Lippoldt Darin	Chief Legal Officer	Feb 13 '24	Sale	132.99	1,098	146,028	39,740	Feb 15 05:45 PM
Cooke Julie	Chief Human Resources Officer	Feb 13 '24	Sale	133.04	796	105,902	17,976	Feb 15 05:35 PM
Delaet Ingrid	Chief Regulatory Officer	Feb 13 '24	Sale	133.03	716	95,253	7,507	Feb 15 05:38 PM
GORMAN KEVIN CHARLES	Chief Executive Officer	Feb 08 '24	Sale	134.15	2,274	305,052	506,962	Feb 08 07:21 PM
Cooke Julie	Chief Human Resources Officer	Feb 08 '24	Sale	135.44	1,329	179,995	17,263	Feb 08 07:35 PM
Boyer David W.	Chief Corp. Affairs Officer	Feb 08 '24	Sale	135.41	1,328	179,830	4,895	Feb 08 07:46 PM
ABERNETHY MATT	Chief Financial Officer	Feb 08 '24	Sale	134.21	980	131,529	30,314	Feb 08 07:12 PM
ROBERTS EIRY	Chief Medical Officer	Feb 08 '24	Sale	134.21	980	131,522	22,717	Feb 08 07:28 PM
Gano Kyle	Chief Business Development Off	Feb 08 '24	Sale	134.20	980	131,519	133,952	Feb 08 07:17 PM
BENEVICH ERIC	Chief Commercial Officer	Feb 08 '24	Sale	134.19	980	131,509	39,631	Feb 08 07:15 PM
Lippoldt Darin	Chief Legal Officer	Feb 08 '24	Sale	134.24	911	122,289	38,755	Feb 08 07:25 PM
GORMAN KEVIN CHARLES	Chief Executive Officer	Feb 06 '24	Sale	142.18	3,040	432,218	504,919	Feb 08 07:21 PM
Gano Kyle	Chief Business Development Off	Feb 06 '24	Sale	142.20	1,600	227,522	133,072	Feb 08 07:17 PM
ABERNETHY MATT	Chief Financial Officer	Feb 06 '24	Sale	142.19	1,280	182,000	29,434	Feb 08 07:12 PM
BENEVICH ERIC	Chief Commercial Officer	Feb 06 '24	Sale	142.12	1,280	181,910	38,751	Feb 08 07:15 PM
Cooke Julie	Chief Human Resources Officer	Feb 06 '24	Sale	142.07	1,215	172,617	17,263	Feb 08 07:35 PM
ROBERTS EIRY	Chief Medical Officer	Feb 06 '24	Sale	142.24	1,121	159,446	21,837	Feb 08 07:28 PM
Lippoldt Darin	Chief Legal Officer	Feb 06 '24	Sale	142.17	1,041	147,995	37,939	Feb 08 07:25 PM
Boyer David W.	Chief Corp. Affairs Officer	Feb 06 '24	Sale	141.96	456	64,734	4,894	Feb 08 07:46 PM
Delaet Ingrid	Chief Regulatory Officer	Feb 01 '24	Sale	139.77	623	87,077	6,865	Feb 02 07:14 PM
GORMAN KEVIN CHARLES	Chief Executive Officer	Jan 31 '24	Sale	140.69	2,707	380,845	502,188	Feb 02 07:21 PM
Boyer David W.	Chief Corp. Affairs Officer	Jan 31 '24	Sale	140.80	2,096	295,115	4,894	Feb 02 07:07 PM
Cooke Julie	Chief Human Resources Officer	Jan 31 '24	Sale	141.29	1,740	245,842	17,263	Feb 02 07:11 PM
Gano Kyle	Chief Business Development Off	Jan 31 '24	Sale	140.70	1,541	216,813	131,635	Feb 02 07:17 PM
ROBERTS EIRY	Chief Medical Officer	Jan 31 '24	Sale	140.79	1,457	205,132	20,832	Feb 02 07:29 PM
ABERNETHY MATT	Chief Financial Officer	Jan 31 '24	Sale	140.72	1,283	180,539	28,284	Feb 02 07:00 PM
Lippoldt Darin	Chief Legal Officer	Jan 31 '24	Sale	140.65	1,250	175,810	37,005	Feb 02 07:24 PM
BENEVICH ERIC	Chief Commercial Officer	Jan 31 '24	Sale	140.78	1,207	169,927	37,601	Feb 02 07:05 PM
Delaet Ingrid	Chief Regulatory Officer	Jan 31 '24	Sale	141.94	422	59,899	6,309	Feb 02 07:14 PM
Onyia Jude	Chief Scientific Officer	Jan 31 '24	Sale	141.94	126	17,884	11,843	Feb 02 07:26 PM
Lippoldt Darin	Chief Legal Officer	Jan 22 '24	Option Exercise	79.02	10,000	790,200	45,882	Jan 24 05:47 PM
Lippoldt Darin	Chief Legal Officer	Jan 22 '24	Sale	139.86	10,000	1,398,553	35,882	Jan 24 05:47 PM
GORMAN KEVIN CHARLES	Chief Executive Officer	Jan 09 '24	Option Exercise	19.59	62,023	1,215,031	561,777	Jan 10 04:31 PM
GORMAN KEVIN CHARLES	Chief Executive Officer	Jan 09 '24	Sale	134.01	62,023	8,311,895	499,754	Jan 10 04:31 PM
GORMAN KEVIN CHARLES	Chief Executive Officer	Jan 08 '24	Option Exercise	19.59	105,835	2,073,308	605,589	Jan 10 04:31 PM
GORMAN KEVIN CHARLES	Chief Executive Officer	Jan 08 '24	Sale	132.44	105,835	14,016,523	499,754	Jan 10 04:31 PM
Gano Kyle	Chief Business Development Off	Jan 02 '24	Option Exercise	19.59	75,000	1,469,250	199,134	Jan 04 06:32 PM
RASTETTER WILLIAM H	Director	Jan 02 '24	Option Exercise	12.98	20,000	259,600	62,785	Jan 04 06:26 PM
Gano Kyle	Chief Business Development Off	Jan 02 '24	Sale	131.47	75,000	9,860,194	130,250	Jan 04 06:32 PM
RASTETTER WILLIAM H	Director	Jan 02 '24	Sale	131.47	11,044	1,451,927	51,741	Jan 04 06:26 PM
Cooke Julie	Chief Human Resources Officer	Dec 22 '23	Option Exercise	73.04	24,000	1,752,900	31,263	Dec 27 04:08 PM
Cooke Julie	Chief Human Resources Officer	Dec 22 '23	Sale	128.66	24,000	3,087,808	17,263	Dec 27 04:08 PM
LYONS GARY A	Director	Dec 22 '23	Sale	130.04	10,000	1,300,443	193,697	Dec 27 04:10 PM
ROBERTS EIRY	Chief Medical Officer	Dec 22 '23	Sale	126.74	10,000	1,267,448	19,521	Dec 27 04:15 PM
ROBERTS EIRY	Chief Medical Officer	Dec 12 '23	Option Exercise	81.05	13,925	1,128,621	36,499	Dec 14 05:22 PM
ROBERTS EIRY	Chief Medical Officer	Dec 12 '23	Sale	120.30	13,925	1,675,240	29,521	Dec 14 05:22 PM
ROBERTS EIRY	Chief Medical Officer	Dec 08 '23	Option Exercise	81.05	300	24,315	29,721	Dec 11 06:18 PM
ROBERTS EIRY	Chief Medical Officer	Dec 08 '23	Sale	120.10	300	36,031	29,521	Dec 11 06:18 PM
ROBERTS EIRY	Chief Medical Officer	Dec 07 '23	Option Exercise	78.52	77,379	6,076,120	68,243	Dec 11 06:18 PM
ROBERTS EIRY	Chief Medical Officer	Dec 07 '23	Sale	120.37	77,379	9,314,319	29,521	Dec 11 06:18 PM
Lippoldt Darin	Chief Legal Officer	Dec 06 '23	Option Exercise	43.24	20,830	900,689	56,712	Dec 08 06:23 PM
ROBERTS EIRY	Chief Medical Officer	Dec 06 '23	Option Exercise	77.81	8,396	653,293	37,917	Dec 08 07:09 PM
Lippoldt Darin	Chief Legal Officer	Dec 06 '23	Sale	119.86	20,830	2,496,648	35,882	Dec 08 06:23 PM
ROBERTS EIRY	Chief Medical Officer	Dec 06 '23	Sale	120.03	8,396	1,007,780	29,521	Dec 08 07:09 PM
LYONS GARY A	Director	Dec 01 '23	Option Exercise	12.98	5,000	64,900	208,697	Dec 05 04:54 PM
LYONS GARY A	Director	Dec 01 '23	Sale	116.77	5,000	583,837	203,697	Dec 05 04:54 PM
Onyia Jude	Chief Scientific Officer	Nov 29 '23	Sale	113.57	2,331	264,733	11,732	Dec 01 05:41 PM
Lippoldt Darin	Chief Legal Officer	Nov 27 '23	Sale	112.27	10,919	1,225,911	35,882	Nov 29 04:36 PM
Boyer David W.	Chief Corp. Affairs Officer	Oct 02 '23	Sale	112.68	1,437	161,921	4,894	Oct 04 05:07 PM
LYONS GARY A	Director	Sep 12 '23	Option Exercise	12.98	5,000	64,900	208,697	Sep 14 04:51 PM

Open in Screener

SLGN

Silgan Holdings Inc.

Apr 25 • 04:00PM ET

47.02

Dollar change -0.30
Percentage change -0.63	%

Consumer Cyclical • Packaging & Containers • USA • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

SLGN Silgan Holdings Inc. daily Stock Chart

Held by: VTI IJH VB VBR VXF FVD REGL IJJ VIG FXR

Index	-	P/E	15.76	EPS (ttm)	2.98	Insider Own	23.13%	Shs Outstand	106.50M	Perf Week	0.38%
Market Cap	5.01B	Forward P/E	11.81	EPS next Y	3.98	Insider Trans	-0.55%	Shs Float	81.87M	Perf Month	2.82%
Income	325.94M	PEG	3.15	EPS next Q	0.66	Inst Own	70.99%	Short Float	2.49%	Perf Quarter	6.91%
Sales	5.99B	P/S	0.84	EPS this Y	6.75%	Inst Trans	0.76%	Short Ratio	3.32	Perf Half Y	14.07%
Book/sh	17.74	P/B	2.65	EPS next Y	9.66%	ROA	4.36%	Short Interest	2.04M	Perf Year	-11.93%
Cash/sh	6.04	P/C	7.79	EPS next 5Y	5.00%	ROE	18.07%	52W Range	38.11 - 54.16	Perf YTD	3.91%
Dividend Est.	0.70 (1.49%)	P/FCF	19.58	EPS past 5Y	8.26%	ROI	7.05%	52W High	-13.18%	Beta	0.69
Dividend TTM	0.73 (1.55%)	Quick Ratio	0.61	Sales past 5Y	6.44%	Gross Margin	16.57%	52W Low	23.38%	ATR (14)	0.85
Dividend Ex-Date	Mar 13, 2024	Current Ratio	1.02	EPS Y/Y TTM	-2.93%	Oper. Margin	10.16%	RSI (14)	50.84	Volatility	1.76% 1.93%
Employees	14520	Debt/Eq	1.94	Sales Y/Y TTM	-6.60%	Profit Margin	5.44%	Recom	2.15	Target Price	53.68
Option/Short	Yes / Yes	LT Debt/Eq	1.45	EPS Q/Q	171.23%	Payout	24.13%	Rel Volume	0.67	Prev Close	47.32
Sales Surprise	-3.60%	EPS Surprise	8.88%	Sales Q/Q	-7.92%	Earnings	May 01 BMO	Avg Volume	615.22K	Price	47.02
SMA20	-1.66%	SMA50	2.77%	SMA200	6.65%	Trades		Volume	413,528	Change	-0.63%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-03-24	Downgrade	Citigroup	Buy → Neutral	$44 → $47
Oct-20-23	Resumed	Raymond James	Outperform	$50 → $55
Jul-27-23	Upgrade	Robert W. Baird	Neutral → Outperform	$53
Apr-27-23	Upgrade	Citigroup	Neutral → Buy	$56
Jan-05-23	Upgrade	Truist	Hold → Buy	$64
Nov-24-21	Initiated	Raymond James	Outperform	$47
Oct-06-21	Initiated	Loop Capital	Buy	$62
Oct-01-21	Downgrade	JP Morgan	Neutral → Underweight	$40
Sep-14-21	Initiated	Truist	Hold	$46
May-20-21	Initiated	Longbow	Buy	$58
Jan-28-21	Upgrade	BofA Securities	Underperform → Buy	$50
Jan-07-21	Downgrade	Citigroup	Buy → Neutral	$46 → $39
Dec-04-20	Upgrade	Wells Fargo	Equal Weight → Overweight	$45
Dec-04-20	Upgrade	Wells Fargo	Equal Weight → Overweight	$43 → $45
Dec-03-20	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$39
Nov-24-20	Downgrade	BofA Securities	Neutral → Underperform
Oct-23-20	Upgrade	Seaport Global Securities	Neutral → Buy	$41
Oct-22-20	Upgrade	CFRA	Hold → Buy
Oct-22-20	Downgrade	BofA Securities	Buy → Neutral	$42
Oct-14-20	Initiated	Seaport Global Securities	Neutral

Show Previous Ratings

Apr-12-24 04:15PM	Silgan to Release First Quarter 2024 Earnings Results on May 1, 2024 (Business Wire)
Mar-18-24 09:40AM	Here's Why Silgan Holdings (SLGN) is a Strong Value Stock (Zacks)
Mar-13-24 09:50AM	Here's Why Silgan Holdings (SLGN) is a Strong Momentum Stock (Zacks)
Mar-01-24 11:30AM	Silgan (SLGN) Down 5.3% Since Last Earnings Report: Can It Rebound? (Zacks)
Feb-29-24 09:40AM	Why Silgan Holdings (SLGN) is a Top Value Stock for the Long-Term (Zacks)
04:30PM	Loading…
Feb-27-24 04:30PM	Silgan Increases Dividend for 20th Consecutive Year Since Initiation and Declares Quarterly Dividend (Business Wire)
Feb-22-24 09:50AM	Why Silgan Holdings (SLGN) is a Top Momentum Stock for the Long-Term (Zacks)
Feb-01-24 10:02AM	Silgan Holdings Inc. (NYSE:SLGN) Q4 2023 Earnings Call Transcript (Insider Monkey)
Jan-31-24 08:23PM	Analyst Report: Silgan Holdings Inc. (Morningstar Research) +5.27%
08:05AM	Silgan Holdings (SLGN) Q4 Earnings Surpass Estimates (Zacks)
06:55AM	Silgan Announces Fourth Quarter and Full Year 2023 Results; Expects Earnings and Free Cash Flow Growth in 2024 (Business Wire)
Jan-18-24 08:23PM	Analyst Report: Silgan Holdings Inc. (Morningstar Research)
Jan-12-24 04:20PM	Silgan to Release Fourth Quarter and Full Year 2023 Earnings Results on January 31, 2024 (Business Wire)
Dec-21-23 08:06PM	Analyst Report: Silgan Holdings Inc. (Morningstar Research)
Oct-31-23 05:00PM	Silgan Declares Quarterly Dividend (Business Wire)
02:31PM	Loading…
Oct-25-23 02:31PM	Analyst Report: Silgan Holdings Inc. (Morningstar Research) -5.77%
06:55AM	Silgan Announces Third Quarter 2023 Results (Business Wire)
Oct-20-23 09:37AM	SolarEdge downgraded, Crocs upgraded: Wall Street's top analyst calls (The Fly)
Oct-06-23 04:40PM	Silgan to Release Third Quarter 2023 Earnings Results on October 25, 2023 (Business Wire)
Sep-01-23 04:20PM	Silgan Announces Participation in Jefferies Industrials Conference (Business Wire)
Aug-10-23 06:24AM	Daily Vickers Top Buyers & Sellers for 08/10/2023 (Argus Research)
Aug-01-23 04:45PM	Silgan Declares Quarterly Dividend (Business Wire)
Jul-26-23 03:14PM	Analyst Report: Silgan Holdings Inc. (Morningstar Research) -12.22%
06:55AM	Silgan Announces Second Quarter 2023 Results (Business Wire)
Jun-26-23 04:15PM	Silgan to Release Second Quarter 2023 Earnings Results on July 26, 2023 (Business Wire)
Jun-21-23 08:00PM	SLGN: Lowering target price to $49.00 (Argus Research)
May-09-23 07:10AM	Gabelli Funds to Host 9th Annual Waste & Sustainability Symposium at the Harvard Club, New York, NY (GlobeNewswire)
May-01-23 06:20PM	Silgan Declares Quarterly Dividend (Business Wire)
Apr-26-23 08:00PM	SLGN: Lowering target price to $51.00 (Argus Research) -9.10%
06:45AM	Silgan Announces First Quarter 2023 Results (Business Wire)
04:30PM	Loading…
Apr-06-23 04:30PM	Silgan Holdings Announces D. Greg Horrigan Will Not Seek Reelection as a Director (Business Wire)
Mar-27-23 04:15PM	Silgan to Release First Quarter 2023 Earnings Results on April 26, 2023 (Business Wire)
Mar-17-23 09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
Mar-08-23 04:45PM	Silgan Holdings Elects Kimberly I. Ulmer as Chief Financial Officer (Business Wire)
Feb-21-23 05:40PM	Silgan Increases Dividend by 12.5 Percent and Declares Quarterly Dividend; Dividend Increased for 19th Consecutive Year Since Initiation (Business Wire)
04:16PM	Silgan Announces Participation in Upcoming Conferences (Business Wire)
Feb-13-23 07:30AM	Daily Vickers Top Buyers & Sellers for 02/13/2023 (Argus Research)
Jan-26-23 12:49PM	Silgan Holdings Inc. (NASDAQ:SLGN) Q4 2022 Earnings Call Transcript (Insider Monkey)
Jan-24-23 06:45PM	Silgan Announces Strong Growth in 2022; Anticipates Increased Revenue, Segment Income and Free Cash Flow In 2023 (Business Wire)
Jan-17-23 10:00AM	Silgan Holdings (SLGN) Earnings Expected to Grow: Should You Buy? (Zacks)
Jan-03-23 04:20PM	Silgan to Release Fourth Quarter and Full Year 2022 Earnings Results on January 24, 2023 (Business Wire)
Nov-28-22 04:30PM	Silgan Holdings Announces Corporate Governance Updates (Business Wire)
Nov-07-22 06:45AM	Silgan Announces Participation in Baird 2022 Global Industrial Conference (Business Wire)
Nov-02-22 04:55PM	Silgan Holdings Increases Size of Its Board of Directors and Elects Niharika Taskar Ramdev as Its Newest Director (Business Wire)
04:30PM	Silgan Holdings Announces Retirement of R. Philip Silver as a Director and Elects Adam J. Greenlee as a Director (Business Wire)
Nov-01-22 05:42PM	Silgan Declares Quarterly Dividend (Business Wire)
Oct-26-22 06:55AM	Silgan Announces All-Time Record Quarterly Earnings; Anticipates Continued Growth and Increased Free Cash Flow In 2023 (Business Wire)
Sep-26-22 04:20PM	Silgan to Release Third Quarter 2022 Earnings Results on October 26, 2022 (Business Wire)
Aug-09-22 06:26AM	Is Now The Time To Put Silgan Holdings (NYSE:SLGN) On Your Watchlist? (Simply Wall St.)
Aug-08-22 04:30PM	Silgan Announces Participation in Jefferies Industrials Conference (Business Wire)
Aug-05-22 09:40AM	Should Value Investors Buy Silgan Holdings (SLGN) Stock? (Zacks)
Aug-03-22 04:30PM	Silgan Declares Quarterly Dividend (Business Wire)
Jul-27-22 08:35AM	Silgan Holdings (SLGN) Q2 Earnings Beat Estimates (Zacks)
07:15AM	Silgan Announces All-Time Record Quarterly Earnings and Estimates Higher Earnings Next Quarter (Business Wire)
Jul-20-22 10:01AM	Silgan Holdings (SLGN) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jul-19-22 08:00AM	Silgan Announces Transfer of Its Common Stock Listing to New York Stock Exchange; to Ring Opening Bell on August 1, 2022 (Business Wire)
Jul-12-22 08:30AM	Silgan Settles With European Commission to End Investigation Since 2015 of Its European Metal Packaging Operations (Business Wire)
05:45AM	EU fines Crown and Silgan 31.5 mln euro for German packaging cartel (Reuters)
Jul-07-22 09:40AM	Why Silgan Holdings (SLGN) is a Top Value Stock for the Long-Term (Zacks)
Jul-04-22 07:46AM	Investing in Silgan Holdings (NASDAQ:SLGN) three years ago would have delivered you a 41% gain (Simply Wall St.)
Jul-01-22 09:40AM	Are Investors Undervaluing Silgan Holdings (SLGN) Right Now? (Zacks)
Jun-28-22 12:30PM	Is Silgan (SLGN) a Suitable Stock for Value Investors Now? (Zacks)
Jun-27-22 04:15PM	Silgan to Release Second Quarter 2022 Earnings Results on July 27, 2022 (Business Wire)
Jun-21-22 10:16AM	Silgan Containers to temporarily lay off 58 in Sacramento (American City Business Journals)
Jun-17-22 03:41AM	Zacks.com featured highlights Cheniere Energy, Nutrien, Imperial Oil, ON Semiconductor and Silgan Holding (Zacks)
Jun-16-22 07:50AM	5 High Earnings Yield Picks Amid Fed's Aggressive Action (Zacks)
Jun-14-22 09:40AM	Is Silgan Holdings (SLGN) Stock Undervalued Right Now? (Zacks)
Jun-02-22 11:38AM	Here's Why Silgan (SLGN) is an Attractive Investment Bet (Zacks)
Jun-01-22 09:40AM	Is Applied Industrial Technologies (AIT) Outperforming Other Industrial Products Stocks This Year? (Zacks)
May-26-22 09:40AM	Is Silgan Holdings (SLGN) a Great Value Stock Right Now? (Zacks)
May-10-22 09:40AM	Has Applied Industrial Technologies (AIT) Outpaced Other Industrial Products Stocks This Year? (Zacks)
May-09-22 01:31PM	Be Wary Of Silgan Holdings (NASDAQ:SLGN) And Its Returns On Capital (Simply Wall St.)
May-05-22 09:40AM	Should Value Investors Buy Silgan Holdings (SLGN) Stock? (Zacks)
May-03-22 04:15PM	Silgan Declares Quarterly Dividend (Business Wire)
Apr-29-22 10:59AM	Silgan (SLGN) Q1 Earnings & Sales Top Estimates, Hikes '22 View (Zacks)
Apr-27-22 08:35AM	Silgan Holdings (SLGN) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
07:58AM	Should You Consider Buying Silgan (SLGN) Shares? (Insider Monkey)
07:15AM	Silgan Announces Record First Quarter Earnings and Raises Full Year Earnings Estimate (Business Wire)
Apr-26-22 09:12AM	Is Silgan Holdings (SLGN) a Smart Long-Term Investment? (Insider Monkey)
Apr-25-22 06:05PM	Crown Holdings (CCK) Q1 Earnings and Revenues Top Estimates (Zacks)
Apr-20-22 03:01PM	Silgan Holdings (SLGN) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Apr-07-22 08:00AM	Should You Be Excited About Silgan Holdings Inc.'s (NASDAQ:SLGN) 23% Return On Equity? (Simply Wall St.)
Mar-28-22 04:15PM	Silgan to Release First Quarter 2022 Earnings Results on April 27, 2022 (Business Wire)
10:20AM	Deere (DE) Hits New 52-Week High: What's Driving it? (Zacks)
09:15AM	Crown (CCK) Soars to 52-Week High, Time to Cash Out? (Zacks)
Mar-25-22 10:10AM	Astec (ASTE) to Buy MINDS Automation, Expand Asphalt Production (Zacks)
Mar-24-22 09:47AM	Lindsay (LNN) Inks Deal With Blyncsy to Enhance Road Safety (Zacks)
Mar-23-22 11:16AM	Sonoco (SON) Ups Q1 Guidance on Strong Demand & Price Recovery (Zacks)
Mar-18-22 09:40AM	Is Silgan Holdings (SLGN) a Great Value Stock Right Now? (Zacks)
Mar-17-22 11:17AM	Crown Holdings (CCK) Hits New 52-Week High: What's Driving it? (Zacks)
Mar-16-22 11:58AM	Solid Demand & Innovation Aid Amcor (AMCR) Amid Cost Inflation (Zacks)
Mar-15-22 11:16AM	Grainger (GWW) Up 19% in 6 Months: What's Driving the Rally? (Zacks)
Mar-11-22 10:08AM	Crown Holdings (CCK) to Build New Beverage Can Plant in U.K. (Zacks)
Mar-09-22 09:16AM	Dover (DOV) Rides on Strong Demand & Cost-Cutting Actions (Zacks)
Mar-08-22 09:50AM	Reasons to Retain Avery Dennison (AVY) Stock in Your Portfolio (Zacks)
Mar-07-22 09:00AM	10 Safe Dividend Stocks to Buy Today (Insider Monkey)
Mar-04-22 04:15PM	Silgan Announces Authorization for Stock Repurchases (Business Wire)
09:51AM	Pentair (PNR) Inks Deal to Acquire Manitowoc Ice for $1.6B (Zacks)
Mar-03-22 11:32AM	Titan International (TWI) Q4 Earnings & Sales Beat, Rise Y/Y (Zacks)
11:12AM	Greif (GEF) Earnings & Sales Surpass Estimates in Q1, Up Y/Y (Zacks)

Silgan Holdings, Inc. engages in the manufacture and sale of rigid packaging solutions. It operates through the following business segments: Dispensing and Specialty Closures, Metal Containers, Custom Containers, and Corporate. The Dispensing and Specialty Closures segment involves the manufacture and sale of finishes. The Metal Containers segment includes steel and aluminum vessels. The Custom Containers segment refers to designed plastic canister. The company was founded by R. Philip Silver and D. Greg Horrigan in 1987 and is headquartered in Stamford, CT.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Prinzen B Frederik	Sr. V.P. - Corp. Dev.	Mar 04 '24	Sale	43.89	4,684	205,591	8,613	Mar 04 06:38 PM
ALLOTT ANTHONY J	Director	Nov 15 '23	Sale	42.00	71,050	2,983,787	574,439	Nov 16 04:31 PM
ALLOTT ANTHONY J	Director	Nov 14 '23	Sale	41.80	10,027	419,135	645,489	Nov 16 04:31 PM
LEWIS ROBERT B	EVP, Corp. Dev. & Admin.	Nov 13 '23	Sale	40.47	25,000	1,011,650	179,229	Nov 15 04:30 PM
Snyder Thomas James	President - Silgan Containers	Nov 08 '23	Sale	41.45	14,323	593,664	85,979	Nov 09 04:29 PM
Snyder Thomas James	President - Silgan Containers	Nov 07 '23	Sale	41.55	10,000	415,456	100,302	Nov 09 04:29 PM
McGrath Stacey J.	Vice President, Tax	Nov 03 '23	Sale	41.90	1,085	45,462	9,078	Nov 03 04:30 PM
Jordan Joseph M	Director	Aug 18 '23	Sale	44.96	2,967	133,398	29,437	Aug 18 05:17 PM
LEWIS ROBERT B	EVP, Corp. Dev. & Admin.	Aug 08 '23	Sale	44.49	14,969	665,903	204,229	Aug 09 04:34 PM
LEWIS ROBERT B	EVP, Corp. Dev. & Admin.	Aug 07 '23	Sale	44.18	10,031	443,217	219,198	Aug 09 04:34 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

KOS

Kosmos Energy Ltd

NBIX

Neurocrine Biosciences, Inc.

SLGN

Silgan Holdings Inc.

Upgrade your FINVIZ experience